Performance of Underlying Securities: NPFI.US tracks the Neurotechnology and Pharmaceutical ETF, so its price is heavily influenced by the performance of companies within these sectors. Positive earnings reports or promising drug developments generally increase the ETF's price.

Investor Sentiment: Overall market sentiment towards the healthcare sector and particularly neurotechnology and pharmaceuticals plays a crucial role. Positive sentiment leads to increased demand and higher prices for NPFI.US.

Interest Rates: Rising interest rates can negatively impact the ETF as they increase borrowing costs for companies within the fund, potentially affecting their profitability and stock valuations.

Economic Conditions: A strong economy usually boosts the healthcare sector as individuals and governments are more likely to invest in treatments and research, thus impacting the ETF's value positively.

Regulatory Changes: New regulations affecting the pharmaceutical or neurotechnology industries can significantly impact the ETF's price, either positively or negatively, depending on the nature of the regulations.

ETF Supply and Demand: The creation and redemption of ETF shares can also influence the market price. High demand compared to supply typically leads to a premium, while high supply and low demand can result in a discount to the net asset value.